6-sulfatoxymelatonin has been researched along with Acute Relapsing Multiple Sclerosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barak, M; Dishon, S; Glass-Marmor, L; Golan, D; Ish-Shalom, S; Lavi, I; Miller, A; Rozenberg, O; Staun-Ram, E | 1 |
Babapour, S; Ghafarpour, M; Ghazizadeh, T; Gholipour, T; Harirchian, MH; Mansouri, B; Siroos, B | 1 |
Golan, D; Lavi, I; Luboshitzky, R; Melamud, L; Miller, A | 1 |
1 trial(s) available for 6-sulfatoxymelatonin and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis.
Topics: Adult; Cholecalciferol; Data Interpretation, Statistical; Depression; Dietary Supplements; Female; Humans; Hydroxycholecalciferols; Male; Melatonin; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Vitamin D; Vitamins | 2013 |
2 other study(ies) available for 6-sulfatoxymelatonin and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
Topics: Adult; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Melatonin; Multiple Sclerosis, Relapsing-Remitting | 2015 |
Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis.
Topics: Adult; Circadian Rhythm; Enzyme-Linked Immunosorbent Assay; Fatigue; Female; Humans; Interferon beta-1b; Interferon-beta; Melatonin; Middle Aged; Motor Activity; Multiple Sclerosis, Relapsing-Remitting; Recombinant Proteins; Sleep Wake Disorders; Young Adult | 2012 |